Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2019-09-09 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
澄清媒體報導
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company clarifying media reports about its business operations and future prospects. It includes a statement from the chairman and references to media coverage and company responses. There are no financial statements, detailed financial data, or regulatory filings such as annual or quarterly reports. The document is under 5,000 characters and serves as a public clarification or regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-09-09 Chinese
108年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, managers, and their family members. It shows the number of shares held, changes in holdings, and other related data. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider holdings, not just an announcement or certification. Therefore, the appropriate classification is DIRS with high confidence.
2019-09-06 Chinese
108年08月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and managers, showing their current holdings, pledged shares, and related information. It is focused on insider share ownership and changes, not on financial results, management changes, or other corporate events. There is no indication of a report publication, earnings release, or regulatory certification. The content matches the description of a Director's Dealing report, which involves personal share transactions or holdings by company directors and executives. The document length is under 5,000 characters and contains detailed insider shareholding data, consistent with a Director's Dealing filing rather than a general regulatory announcement or other report types.
2019-09-06 Chinese
108年8月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍, with data for August 2019 (民國108年08月). It includes percentage changes compared to the previous year and notes on accounting standards (IFRS) and reporting requirements. The document is short (765 characters) and primarily presents financial summary data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release with key highlights. It is more of a regulatory or compliance disclosure of revenue figures. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2019-09-06 Chinese
108年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, providing information about fund loans and endorsement guarantees for the current and previous months, with amounts all zero. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. It does not contain any narrative, management discussion, or comprehensive financial data. It is a regulatory disclosure of specific financial information but not a full report or announcement of a report. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2019-09-06 Chinese
108年第2季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure related to investment in overseas subsidiaries, showing investment amounts, holding percentages, and recognized investment gains or losses for a specific quarter (108年2季, which corresponds to Q2 of the 108th year in the Taiwanese calendar, roughly 2019). The content is tabular and concise, focusing on investment details rather than a full financial report. The document length is only 664 characters, indicating it is a short disclosure rather than a comprehensive report. It does not contain full financial statements or detailed analysis, so it is not an Interim/Quarterly Report (IR) or Annual Report (10-K). It is a regulatory disclosure of investment information, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2019-09-05 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.